Adaptin Bio APTN
OTC APTN
$6.27 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Adaptin Bio (APTN) Debt Ratio (2022 - 2026)

Updated

Adaptin Bio's Debt Ratio came in at 0.17 for Q2 2026, down 51.5% from the prior quarter.

Analysis

Adaptin Bio (APTN) Debt Ratio (2022 - 2026) Analysis & Trends

For FY2024, Adaptin Bio's Debt Ratio was 6.36, down 97.0% from FY2023.

  • Going back by year, Debt Ratio was 213.73 in FY2023 and 0.61 in FY2022.
  • The Q2 2026 figure represents the lowest quarterly Debt Ratio in data going back to Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 0.24
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 0.52
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 0.42
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 0.31
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 0.00
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 0.60
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 0.53
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Adaptin Bio 56.76 Mn 54.75 Mn - 0.17
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.17
Mar 31, 2026 0.34
Dec 31, 2024 6.36
Sep 30, 2024 427.84
Jun 30, 2024 349.60
Mar 31, 2024 213.73
Dec 31, 2023 213.73
Sep 30, 2023 60.19
Dec 31, 2022 0.61
API Access

Adaptin Bio Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=APTN&period=max&api_key=YOUR_API_KEY